In Fig. 4A, we assessed the viability of LKB1mut and LKB1wt NSCLC cells co-cultured with NSCLC patients-derived PBMCs pre-treated with MET alone or in combination with an anti-PD-L1. Here, MET is linked to non-small cell lung carcinoma.